1) Helicobacter pylori/pathogenicity
幽门螺旋杆菌/致病力
2) helicobacter pylori
幽门螺旋杆菌
1.
Study on the Fermentation Technology for Helicobacter pylori Cultivation;
培养幽门螺旋杆菌的发酵工艺研究
2.
Study on the relationship between Helicobacter pylori infection and idiopathic thrombocytopenic purpura in children;
儿童特发性血小板减少性紫癜与幽门螺旋杆菌的关系
3.
Gastric mucosal cytokine changes post-Helicobacter pylori infection in mongolian gerbils;
蒙古沙鼠感染幽门螺旋杆菌后胃黏膜细胞因子水平的改变
3) H.pylori
幽门螺旋杆菌
1.
Prevalence of H.pylori infection in cerebral infarction patients and the association between H.pylori infection and cerebral infarction;
脑梗死患者幽门螺旋杆菌感染状况调查及其致病危险性分析
2.
Objective:This study examined the quality of life(QOL) of patients with FD following H.
目的:探讨幽门螺旋杆菌(HP)治疗对功能性消化不良(FD)治疗的意义。
3.
OBJECTIVE:To investigate the H.
目的:通过比较胃癌低发区广东省胃癌患者与匹配人群的幽门螺旋杆菌(Helicobacterpylori,H。
4) HP
幽门螺旋杆菌
1.
Optimizing the Best Medium of HP by Orthogonal Test Design;
正交试验优选幽门螺旋杆菌培养条件
2.
The Rearch on the Relationship between IL 1B 511 Gene Polymorphism and HP Infection and Stomach Carcinoma;
IL-1B-511基因多态性及幽门螺旋杆菌感染与胃癌的关系研究
3.
The Study on Relationship between Acute Cerebral Infarction and Chronic Helicobacter Pylori(Hp)Infection with ~(13)C-UREA-Breath Test;
~(13)C尿素呼气实验用于慢性幽门螺旋杆菌感染与脑梗死关系的研究
5) Helicobacter pylori (HP)
幽门螺旋杆菌
1.
Objective To evaluate the value of Protein Chi p Detection System (PCDS) for Helicobacter pylori (Hp) in clinical diagnosis.
目的 考察幽门螺旋杆菌蛋白芯片检测系统及试剂的临床应用前景。
2.
Objective: To discuss the therapeutic efficacy and security of omeprazol, clarithromycin and bismuth triple therapy with short term in eradication of helicobacter pylori (Hp).
目的:探讨奥美拉唑、克拉霉素、铋剂短程三联治疗幽门螺旋杆菌 (Hp)感染患者的疗效和安全性。
3.
Objective: It is to study the relationship between TCM syndrome-type of Hp-associated gastritis dampness-heat in spleen and stomach、deficiency in spleen and stomach and Helicobacter pylori (Hp).
目的:探讨脾胃湿热、脾胃虚弱型幽门螺旋杆菌相关性慢性胃炎(HpAG,下同)与幽门螺旋杆菌(Hp,下同)的关系。
6) Helicobacter pylori(Hp)
幽门螺旋杆菌(Hp)
补充资料：致病性大肠杆菌
致病性大肠杆菌
enteropathogenic coli,EPEC
婴儿腹泻的主要致病菌，严重者可致死。本组细菌不产生肠毒素，它们主要寄生在十二指肠、空肠和回肠上端。其致病机制不清，但已发现某些血清型大肠杆菌是致病性大肠杆菌，本组细菌常对多种抗菌素具有耐药性。该组疾病的诊断主要依靠临床症状及细菌血清学鉴定。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条